Caveat Emptor: Direct-to-Consumer (DTC) Ads for Testosterone Replacement Therapy Soar

Tweet “Ted,” a 50-year-old bicycle racer from Philadelphia, saw his primary care doctor for the last time several months ago– when he was advised to start testosterone replacement therapy. “Your labs are excellent,” said Ted’s doctor. “I’d like to frame them.” The lab values included a normal range testosterone level. Ted was there for a

Testosterone Replacement Trials Proceed Slowly

Tweet (part 2 of 2 posts) Alerting men to screening and treatment for low testosterone may get them in to their doctors faster, but they may be astounded to learn that the science in the field is wanting. The National Institute of Aging only enrolled its first patient in a testosterone replacement trial a little

AARP: Stakeholder for Waste and Moneyed Interests?

Tweet AARP, you lost whatever presumed credibility you thought you had with one article in the current issue of your magazine. I am talking about the hard copy of “All the President’s Scans: Our Commander in Chief Regularly Gets An Extensive Physical: Should You?” – part of your Spring 2016 Health Special in AARP: The